{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:12:17Z","timestamp":1790745137372,"version":"4.1.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Antimicrob Resist"],"DOI":"10.1038\/s44259-025-00173-5","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T17:36:05Z","timestamp":1765906565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Emerging antifungal resistance in Candida parapsilosis: the end of the innocence"],"prefix":"10.1038","volume":"3","author":[{"given":"Jes\u00fas","family":"Guinea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Cadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"173_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a019778","volume":"4","author":"SA Turner","year":"2014","unstructured":"Turner, S. A. & Butler, G. The Candida pathogenic species complex. Cold Spring Harb. Perspect. Med. 4, 1\u201318 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"173_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/dnares\/dsac010","volume":"29","author":"V Mix\u00e3o","year":"2022","unstructured":"Mix\u00e3o, V. et al. Genome analysis of five recently described species of the CUG-Ser clade uncovers Candida theae as a new hybrid lineage with pathogenic potential in the Candida parapsilosis species complex. DNA Res. 29, dsac010 (2022).","journal-title":"DNA Res."},{"key":"173_CR3","doi-asserted-by":"publisher","first-page":"102491","DOI":"10.1016\/j.mib.2024.102491","volume":"80","author":"V Del Olmo","year":"2024","unstructured":"Del Olmo, V. & Gabald\u00f3n, T. Hybrids unleashed: exploring the emergence and genomic insights of pathogenic yeast hybrids. Curr. Opin. Microbiol 80, 102491 (2024).","journal-title":"Curr. Opin. Microbiol"},{"key":"173_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00961-8","author":"M Govrins","year":"2023","unstructured":"Govrins, M. & Lass-Fl\u00f6rl, C. Candida parapsilosis complex in the clinical setting. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/s41579-023-00961-8 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"173_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","volume":"87","author":"MC Arendrup","year":"2023","unstructured":"Arendrup, M. C. et al. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study. J. Infect. 87, 428\u2013437 (2023).","journal-title":"J. Infect."},{"key":"173_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"C Lass-Fl\u00f6rl","year":"2024","unstructured":"Lass-Fl\u00f6rl, C. et al. Invasive candidiasis. Nat. Rev. Dis. Prim. 10, 20 (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"173_CR7","doi-asserted-by":"publisher","first-page":"myad131","DOI":"10.1093\/mmy\/myad131","volume":"62","author":"M Asogan","year":"2024","unstructured":"Asogan, M. et al. Candida parapsilosis: a systematic review to inform the World Health Organization fungal priority pathogens list. Med. Mycol. 62, myad131 (2024).","journal-title":"Med. Mycol."},{"key":"173_CR8","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1086\/599039","volume":"48","author":"DL Horn","year":"2009","unstructured":"Horn, D. L. et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48, 1695\u20131703 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"173_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106229","volume":"89","author":"J Salmanton-Garc\u00eda","year":"2024","unstructured":"Salmanton-Garc\u00eda, J. et al. Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study. J. Infect. 89, 106229 (2024).","journal-title":"J. Infect."},{"key":"173_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41591-019-0709-7","volume":"26","author":"B Zhai","year":"2020","unstructured":"Zhai, B. et al. High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat. Med. 26, 59\u201364 (2020).","journal-title":"Nat. Med."},{"key":"173_CR11","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1097\/INF.0b013e3182863a1c","volume":"32","author":"M Pammi","year":"2013","unstructured":"Pammi, M., Holland, L., Butler, G., Gacser, A. & Bliss, J. M. Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. Pediatr. Infect. Dis. J. 32, e206\u2013e216 (2013).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"173_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0376-2","volume":"24","author":"S Neji","year":"2017","unstructured":"Neji, S. et al. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens. J. Biomed. Sci. 24, 67 (2017).","journal-title":"J. Biomed. Sci."},{"key":"173_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature17625","volume":"532","author":"DL Moyes","year":"2016","unstructured":"Moyes, D. L. et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532, 64\u201368 (2016).","journal-title":"Nature"},{"key":"173_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03510-21","volume":"13","author":"JP Richardson","year":"2022","unstructured":"Richardson, J. P. et al. Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins. mBio 13, e0351021 (2022).","journal-title":"mBio"},{"key":"173_CR15","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S2666-5247(23)00067-8","volume":"4","author":"F Daneshnia","year":"2023","unstructured":"Daneshnia, F. et al. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe 4, e470\u2013e480 (2023).","journal-title":"Lancet Microbe"},{"key":"173_CR16","doi-asserted-by":"publisher","first-page":"e0002923","DOI":"10.1128\/mmbr.00029-23","volume":"88","author":"T Gabald\u00f3n","year":"2024","unstructured":"Gabald\u00f3n, T. Threats from the Candida parapsilosis complex: the surge of multidrug resistance and a hotbed for new emerging pathogens. Microbiol. Mol. Biol. Rev. 88, e0002923 (2024).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"173_CR17","doi-asserted-by":"publisher","unstructured":"Bartalucci, C., Vena, A., Giacobbe, D. R. & Bassetti, M. Clinical impact of fluconazole-resistant Candida parapsilosis: a narrative review. Fut. Microbiol. 1\u201310, https:\/\/doi.org\/10.1080\/17460913.2025.2544443 (2025).","DOI":"10.1080\/17460913.2025.2544443"},{"key":"173_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/cid\/ciae603","volume":"80","author":"A Vena","year":"2025","unstructured":"Vena, A. et al. Impact of fluconazole resistance on the outcomes of patients with Candida parapsilosis bloodstream infections: a retrospective multicenter study. Clin. Infect. Dis. 80, 540\u2013550 (2025).","journal-title":"Clin. Infect. Dis."},{"key":"173_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13756-025-01559-w","volume":"14","author":"C Semet","year":"2025","unstructured":"Semet, C. et al. Risk factors and outcome for bloodstream infections due to fluconazole-resistant Candida parapsilosis: a 22-year single-center retrospective study. Antimicrob. Resist. Infect. Control 14, 49 (2025).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"173_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.012","volume":"6","author":"PJT Brassington","year":"2025","unstructured":"Brassington, P. J. T. et al. Genomic reconstruction of an azole-resistant Candida parapsilosis outbreak and the creation of a multi-locus sequence typing scheme: a retrospective observational and genomic epidemiology study. Lancet Microbe 6, 100949 (2025).","journal-title":"Lancet Microbe"},{"key":"173_CR21","doi-asserted-by":"publisher","first-page":"e0071022","DOI":"10.1128\/aac.00710-22","volume":"66","author":"J D\u00edaz-Garc\u00eda","year":"2022","unstructured":"D\u00edaz-Garc\u00eda, J. et al. Evidence of fluconazole-resistant Candida parapsilosis genotypes spreading across hospitals located in Madrid, Spain and Harboring the Y132F ERG11p Substitution. Antimicrobial Agents Chemother. 66, e0071022 (2022).","journal-title":"Antimicrobial Agents Chemother."},{"key":"173_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41579-023-00861-x","volume":"21","author":"MC Fisher","year":"2023","unstructured":"Fisher, M. C. & Denning, D. W. The WHO fungal priority pathogens list as a game-changer. Nat. Rev. Microbiol. 21, 211\u2013212 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"173_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jhin.2004.06.033","volume":"59","author":"LA Bonassoli","year":"2005","unstructured":"Bonassoli, L. A., Bertoli, M. & Svidzinski, T. I. E. High frequency of Candida parapsilosis on the hands of healthy hosts. J. Hospital Infect. 59, 159\u2013162 (2005).","journal-title":"J. Hospital Infect."},{"key":"173_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.vetmic.2017.07.031","volume":"212","author":"RdeA Cordeiro","year":"2017","unstructured":"Cordeiro, R. deA. et al. Candida parapsilosis complex in veterinary practice: a historical overview, biology, virulence attributes and antifungal susceptibility traits. Vet. Microbiol. 212, 22\u201330 (2017).","journal-title":"Vet. Microbiol."},{"key":"173_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2217\/fmb-2021-0166","volume":"17","author":"G Dornelles","year":"2022","unstructured":"Dornelles, G. et al. Harris\u2019 hawk (Parabuteo unicinctus) as a source of pathogenic human yeasts: a potential risk to human health. Fut. Microbiol. 17, 169\u2013175 (2022).","journal-title":"Fut. Microbiol."},{"key":"173_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-020-02251-5","author":"AM Glushakova","year":"2020","unstructured":"Glushakova, A. M., Rodionova, E. N. & Kachalkin, A. V. Yeasts in Feces of Pigeons (Columba livia) in the City of Moscow. Curr. Microbiol. https:\/\/doi.org\/10.1007\/s00284-020-02251-5 (2020).","journal-title":"Curr. Microbiol."},{"key":"173_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/myc.13404","volume":"65","author":"D Castelo-Branco","year":"2022","unstructured":"Castelo-Branco, D. et al. Collateral consequences of agricultural fungicides on pathogenic yeasts: a one health perspective to tackle azole resistance. Mycoses 65, 303\u2013311 (2022).","journal-title":"Mycoses"},{"key":"173_CR28","doi-asserted-by":"publisher","unstructured":"Castelo-Branco, D. de S. C. M. et al. Azole resistance in Candida from animals calls for the One Health approach to tackle the emergence of antimicrobial resistance. Med. Mycol. 1\u201310, https:\/\/doi.org\/10.1093\/mmy\/myz135 (2020).","DOI":"10.1093\/mmy\/myz135"},{"key":"173_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsyr\/foz032","volume":"19","author":"DA Opulente","year":"2019","unstructured":"Opulente, D. A. et al. Pathogenic budding yeasts isolated outside of clinical settings. FEMS Yeast Res. 19, 1\u20136 (2019).","journal-title":"FEMS Yeast Res."},{"key":"173_CR30","doi-asserted-by":"publisher","first-page":"foz080","DOI":"10.1093\/femsyr\/foz080","volume":"20","author":"F Morio","year":"2020","unstructured":"Morio, F. Dear medical mycologists, it is time to look outside the box. FEMS Yeast Res. 20, foz080 (2020).","journal-title":"FEMS Yeast Res."},{"key":"173_CR31","doi-asserted-by":"publisher","unstructured":"Vadkertiova, R., Dudasova, H. & Balascakova, M. Yeasts in agricultural and managed soils. In Yeasts in Natural Ecosystems: Diversity 1\u2013499, https:\/\/doi.org\/10.1007\/978-3-319-62683-3 (2017).","DOI":"10.1007\/978-3-319-62683-3"},{"key":"173_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jinf.2017.06.005","volume":"75","author":"H-J Lo","year":"2017","unstructured":"Lo, H.-J. et al. Fruits as the vehicle of drug resistant pathogenic yeasts. J. Infect. 75, 254\u2013262 (2017).","journal-title":"J. Infect."},{"key":"173_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.funbio.2023.06.001","volume":"127","author":"\u0410\u041c Glushakova","year":"2023","unstructured":"Glushakova, \u0410\u041c & Kachalkin, \u0410V. Yeast community succession in cow dung composting process. Fungal Biol. 127, 1075\u20131083 (2023).","journal-title":"Fungal Biol."},{"key":"173_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.174662","volume":"947","author":"LS Ramos","year":"2024","unstructured":"Ramos, L. S. et al. Candida spp. isolated from recreational coastal waters of Rio de Janeiro - Brazil: focus on antifungal resistance and virulence attributes. Sci. Total Environ. 947, 174662 (2024).","journal-title":"Sci. Total Environ."},{"key":"173_CR35","doi-asserted-by":"publisher","first-page":"e00968","DOI":"10.1128\/AAC.00968-18","volume":"62","author":"Z Liu","year":"2018","unstructured":"Liu, Z., Rossi, J. M. & Myers, L. C. Candida albicans Zn cluster transcription factors Tac1 and Znc1 are activated by farnesol to upregulate a transcriptional program including the multidrug efflux pump CDR1. Antimicrobial Agents Chemother. 62, e00968\u201318 (2018).","journal-title":"Antimicrobial Agents Chemother."},{"key":"173_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9358542","volume":"2020","author":"MG Arroyo","year":"2020","unstructured":"Arroyo, M. G. et al. Broad diversity of fungi in hospital water. Sci. World J. 2020, 1\u20136 (2020).","journal-title":"Sci. World J."},{"key":"173_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jhin.2022.02.006","volume":"123","author":"A Prigitano","year":"2022","unstructured":"Prigitano, A. et al. ICU environmental surfaces are a reservoir of fungi: species distribution in northern Italy. J. Hosp. Infect. 123, 74\u201379 (2022).","journal-title":"J. Hosp. Infect."},{"key":"173_CR38","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1017\/ice.2017.127","volume":"38","author":"CT Piedrahita","year":"2017","unstructured":"Piedrahita, C. T. et al. Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and Other Candida Species. Infect. Control Hosp. Epidemiol. 38, 1107\u20131109 (2017).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"173_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/21505594.2022.2026037","volume":"13","author":"S Allert","year":"2022","unstructured":"Allert, S. et al. From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris. Virulence 13, 191\u2013214 (2022).","journal-title":"Virulence"},{"key":"173_CR40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/mmy\/myx008","volume":"55","author":"A D\u00f6gen","year":"2017","unstructured":"D\u00f6gen, A. et al. Candida parapsilosis in domestic laundry machines. Med. Mycol. 55, 813\u2013819 (2017).","journal-title":"Med. Mycol."},{"key":"173_CR41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jiph.2020.01.008","volume":"13","author":"L Fu","year":"2020","unstructured":"Fu, L. et al. Different efficacies of common disinfection methods against Candida auris and other Candida species. J. Infect. Public Health 13, 730\u2013736 (2020).","journal-title":"J. Infect. Public Health"},{"key":"173_CR42","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1017\/ice.2017.162","volume":"38","author":"JL Cadnum","year":"2017","unstructured":"Cadnum, J. L. et al. Effectiveness of disinfectants against Candida auris and other Candida Species. Infect. Control Hosp. Epidemiol. 38, 1240\u20131243 (2017).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"173_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fmed.2018.00028","volume":"5","author":"M Cavalheiro","year":"2018","unstructured":"Cavalheiro, M. & Teixeira, M. C. Candida biofilms: threats, challenges, and promising strategies. Front. Med. 5, 28 (2018).","journal-title":"Front. Med."},{"key":"173_CR44","doi-asserted-by":"publisher","first-page":"e00111","DOI":"10.1128\/CMR.00111-18","volume":"32","author":"R T\u00f3th","year":"2019","unstructured":"T\u00f3th, R. et al. Candida parapsilosis: from genes to the bedside. Clin. Microbiol. Rev. 32, e00111\u201318 (2019).","journal-title":"Clin. Microbiol. Rev."},{"key":"173_CR45","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/mmy\/myz127","volume":"58","author":"H Heaney","year":"2020","unstructured":"Heaney, H. et al. The environmental stress sensitivities of pathogenic Candida species, including candida auris, and implications for their spread in the hospital setting. Med. Mycol. 58, 744\u2013755 (2020).","journal-title":"Med. Mycol."},{"key":"173_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53442-8","volume":"15","author":"L Lombardi","year":"2024","unstructured":"Lombardi, L. et al. Alternative sulphur metabolism in the fungal pathogen Candida parapsilosis. Nat. Commun. 15, 9190 (2024).","journal-title":"Nat. Commun."},{"key":"173_CR47","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1128\/AAC.00262-08","volume":"52","author":"G Garcia-Effron","year":"2008","unstructured":"Garcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D. & Perlin, D. S. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob. Agents Chemother. 52, 2305\u20132312 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR48","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1128\/AAC.02155-13","volume":"58","author":"J Guinea","year":"2014","unstructured":"Guinea, J. et al. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob. Agents Chemother. 58, 1529\u20131537 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR49","doi-asserted-by":"publisher","first-page":"myad072","DOI":"10.1093\/mmy\/myad072","volume":"61","author":"J D\u00edaz-Garc\u00eda","year":"2023","unstructured":"D\u00edaz-Garc\u00eda, J. et al. Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity. Med. Mycol. 61, myad072 (2023).","journal-title":"Med. Mycol."},{"key":"173_CR50","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/jac\/dkaa419","volume":"76","author":"A Arastehfar","year":"2021","unstructured":"Arastehfar, A. et al. Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?. J. Antimicrobial. Chemother. 76, 418\u2013422 (2021).","journal-title":"J. Antimicrobial. Chemother."},{"key":"173_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2153086","volume":"12","author":"Y Ning","year":"2023","unstructured":"Ning, Y. et al. Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Emerg. Microbes Infect. 12, 2153086 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"173_CR52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/jof8090931","volume":"8","author":"M Siopi","year":"2022","unstructured":"Siopi, M. et al. Pan-echinocandin resistant C. parapsilosis harboring an F652S Fks1 alteration in a patient with prolonged echinocandin therapy. J. Fungi 8, 931 (2022).","journal-title":"J. Fungi"},{"key":"173_CR53","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1080\/22221751.2022.2117093","volume":"11","author":"F Daneshnia","year":"2022","unstructured":"Daneshnia, F. et al. Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU. Emerg. Microbes Infect. 11, 2264\u20132274 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"173_CR54","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","volume":"6","author":"MA Pfaller","year":"2019","unstructured":"Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M. & Jones, R. N. Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997-2016. Open Forum Infect. Dis. 6, S79\u2013S94 (2019).","journal-title":"Open Forum Infect. Dis."},{"key":"173_CR55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/jof7040259","volume":"7","author":"DY Thomaz","year":"2021","unstructured":"Thomaz, D. Y. et al. Environmental clonal spread of azole-resistant Candida parapsilosis with Erg11-Y132F mutation causing a large candidemia outbreak in a Brazilian cancer referral center. J. Fungi 7, 259 (2021).","journal-title":"J. Fungi"},{"key":"173_CR56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/myc.13070","volume":"63","author":"RE Magobo","year":"2020","unstructured":"Magobo, R. E., Lockhart, S. R. & Govender, N. P. Fluconazole-resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa. Mycoses 63, 471\u2013477 (2020).","journal-title":"Mycoses"},{"key":"173_CR57","doi-asserted-by":"publisher","first-page":"2300661","DOI":"10.2807\/1560-7917.ES.2024.29.29.2300661","volume":"29","author":"M Siopi","year":"2024","unstructured":"Siopi, M. et al. Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023. Eur. Surveill. 29, 2300661 (2024).","journal-title":"Eur. Surveill."},{"key":"173_CR58","doi-asserted-by":"publisher","first-page":"e01827","DOI":"10.1128\/AAC.01827-20","volume":"65","author":"J D\u00edaz-Garc\u00eda","year":"2021","unstructured":"D\u00edaz-Garc\u00eda, J. et al. Monitoring the epidemiology and antifungal resistance of yeasts causing fungemia in a tertiary care hospital in madrid, spain: any relevant changes in the last 13 years?. Antimicrob. Agents Chemother. 65, e01827\u201320 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR59","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jiph.2024.04.009","volume":"17","author":"G Caggiano","year":"2024","unstructured":"Caggiano, G. et al. Genotypic and phenotypic characteristics of Candida parapsilosis bloodstream isolates: health care associated infections in a teaching Hospital in Italy. J. Infect. Public Health 17, 967\u2013974 (2024).","journal-title":"J. Infect. Public Health"},{"key":"173_CR60","doi-asserted-by":"publisher","unstructured":"McHugh, J., Chesdachai, S., Dunsirn, M., Wengenack, N. & Vergidis, P. Increasing fluconazole resistance in Candida parapsilosis: a 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015-2024). J. Infect. Dis. jiaf249 https:\/\/doi.org\/10.1093\/infdis\/jiaf249 (2025).","DOI":"10.1093\/infdis\/jiaf249"},{"key":"173_CR61","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nature08064","volume":"459","author":"G Butler","year":"2009","unstructured":"Butler, G. et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459, 657\u2013662 (2009).","journal-title":"Nature"},{"key":"173_CR62","doi-asserted-by":"publisher","first-page":"D592","DOI":"10.1093\/nar\/gkw924","volume":"45","author":"MS Skrzypek","year":"2017","unstructured":"Skrzypek, M. S. et al. The Candida Genome Database (CGD): incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data. Nucleic Acids Res. 45, D592\u2013D596 (2017).","journal-title":"Nucleic Acids Res."},{"key":"173_CR63","doi-asserted-by":"publisher","DOI":"10.1128\/mra.00347-24","volume":"13","author":"S Mutalov\u00e1","year":"2024","unstructured":"Mutalov\u00e1, S. et al. Chromosome-level genome assembly of an auxotrophic strain of the pathogenic yeast Candida parapsilosis. Microbiol. Resour. Announc. 13, e0034724 (2024).","journal-title":"Microbiol. Resour. Announc."},{"key":"173_CR64","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1128\/AAC.04613-14","volume":"59","author":"NT Grossman","year":"2015","unstructured":"Grossman, N. T., Pham, C. D., Cleveland, A. A. & Lockhart, S. R. Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system. Antimicrob. Agents Chemother. 59, 1030\u20131037 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR65","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1128\/AAC.01358-15","volume":"59","author":"EL Berkow","year":"2015","unstructured":"Berkow, E. L. et al. Multidrug transporters and alterations in sterol biosynthesis contribute to azole antifungal resistance in Candida parapsilosis. Antimicrob. Agents Chemother. 59, 5942\u20135950 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR66","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1128\/AAC.01177-15","volume":"59","author":"ACR Souza","year":"2015","unstructured":"Souza, A. C. R. et al. Candida parapsilosis resistance to fluconazole: molecular mechanisms and in vivo impact in infected Galleria mellonella larvae. Antimicrob. Agents Chemother. 59, 6581\u20136587 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR67","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jac\/dkz029","volume":"74","author":"A Singh","year":"2019","unstructured":"Singh, A. et al. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India. J. Antimicrob. Chemother. 74, 1260\u20131268 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"173_CR68","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3201\/eid2409.180625","volume":"24","author":"YJ Choi","year":"2018","unstructured":"Choi, Y. J. et al. Fluconazole-resistant Candida parapsilosis bloodstream isolates with Y132F mutation in ERG11 gene, South Korea. Emerg. Infect. Dis. 24, 1768\u20131770 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"173_CR69","doi-asserted-by":"publisher","first-page":"105799","DOI":"10.1016\/j.ijantimicag.2019.09.003","volume":"55","author":"M Castanheira","year":"2020","unstructured":"Castanheira, M., Deshpande, L. M., Messer, S. A., Rhomberg, P. R. & Pfaller, M. A. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Int. J. Antimicrob. Agents 55, 105799 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"173_CR70","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fcimb.2020.00232","volume":"10","author":"C Martini","year":"2020","unstructured":"Martini, C. et al. Prevalence and clonal distribution of azole-resistant Candida parapsilosis isolates causing bloodstream infections in a large Italian hospital. Front. Cell. Infect. Microbiol. 10, 232 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"173_CR71","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/jac\/dkad356","volume":"79","author":"Y-T Ning","year":"2024","unstructured":"Ning, Y.-T. et al. Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China. J. Antimicrob. Chemother. 79, 128\u2013133 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"173_CR72","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.3389\/fmicb.2018.02997","volume":"9","author":"DY Thomaz","year":"2018","unstructured":"Thomaz, D. Y. et al. An azole-resistant Candida parapsilosis outbreak: clonal persistence in the intensive care unit of a Brazilian Teaching Hospital. Front. Microbiol. 9, 2997 (2018).","journal-title":"Front. Microbiol."},{"key":"173_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/jof8020183","volume":"8","author":"RK Hare","year":"2022","unstructured":"Hare, R. K. et al. Candidemia among hospitalized pediatric patients caused by several clonal lineages of Candida parapsilosis. J. Fungi 8, 183 (2022).","journal-title":"J. Fungi"},{"key":"173_CR74","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/myc.13296","volume":"64","author":"S Demirci-Duarte","year":"2021","unstructured":"Demirci-Duarte, S., Arikan-Akdagli, S. & G\u00fclmez, D. Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years. Mycoses 64, 823\u2013830 (2021).","journal-title":"Mycoses"},{"key":"173_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myaa098","author":"DE Corzo-Leon","year":"2020","unstructured":"Corzo-Leon, D. E., Peacock, M., Rodriguez-Zulueta, P., Salazar-Tamayo, G. J. & MacCallum, D. M. General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation. Med. Mycol. https:\/\/doi.org\/10.1093\/mmy\/myaa098 (2020).","journal-title":"Med. Mycol."},{"key":"173_CR76","doi-asserted-by":"publisher","first-page":"e01001","DOI":"10.1128\/AAC.01001-20","volume":"64","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar, A. et al. First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey. Antimicrob. Agents Chemother. 64, e01001\u2013e01020 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR77","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fcimb.2020.00206","volume":"10","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar, A. et al. Evaluation of molecular epidemiology, clinical characteristics, antifungal susceptibility profiles, and molecular mechanisms of antifungal resistance of Iranian Candida parapsilosis species complex blood isolates. Front. Cell Infect. Microbiol. 10, 206 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"173_CR78","doi-asserted-by":"publisher","first-page":"676177","DOI":"10.3389\/fcimb.2021.676177","volume":"11","author":"A Arastehfar","year":"2021","unstructured":"Arastehfar, A. et al. Clonal candidemia outbreak by Candida parapsilosis carrying Y132F in Turkey: evolution of a persisting challenge. Front. Cell Infect. Microbiol. 11, 676177 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"173_CR79","doi-asserted-by":"publisher","unstructured":"Bergin, S. et al. Analysis of clinical Candida parapsilosis isolates reveals copy number variation in key fluconazole resistance genes. Antimicrob. Agents Chemotherapy e0161923, https:\/\/doi.org\/10.1128\/aac.01619-23 (2024).","DOI":"10.1128\/aac.01619-23"},{"key":"173_CR80","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1089\/mdr.2016.0336","volume":"23","author":"M Asadzadeh","year":"2017","unstructured":"Asadzadeh, M., Ahmad, S., Al-Sweih, N. & Khan, Z. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait. Microb. Drug Resist. 23, 966\u2013972 (2017).","journal-title":"Microb. Drug Resist."},{"key":"173_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01633-20","volume":"65","author":"M Asadzadeh","year":"2021","unstructured":"Asadzadeh, M., Dashti, M., Ahmad, S., Alfouzan, W. & Alameer, A. Whole-genome and targeted-amplicon sequencing of fluconazole-susceptible and -resistant Candida parapsilosis isolates from Kuwait reveals a previously undescribed N1132D polymorphism in CDR1. Antimicrob. Agents Chemother. 65, 1\u20133 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70062","volume":"68","author":"V Sharma","year":"2025","unstructured":"Sharma, V. et al. Genotypic diversity and molecular basis of fluconazole resistance in Candida parapsilosis clinical isolates collected over 7 years in a tertiary-care hospital in North India. Mycoses 68, e70062 (2025).","journal-title":"Mycoses"},{"key":"173_CR83","doi-asserted-by":"publisher","first-page":"1602.e1","DOI":"10.1016\/j.cmi.2023.08.030","volume":"29","author":"LA Doorley","year":"2023","unstructured":"Doorley, L. A., Barker, K. S., Zhang, Q., Rybak, J. M. & Rogers, P. D. Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosis. Clin. Microbiol. Infect. 29, 1602.e1\u20131602.e7 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"173_CR84","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00022-24","volume":"68","author":"S Hartuis","year":"2024","unstructured":"Hartuis, S. et al. Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis. Antimicrob. Agents Chemother. 68, e0002224 (2024).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR85","doi-asserted-by":"publisher","first-page":"575.e1","DOI":"10.1016\/j.cmi.2017.02.002","volume":"23","author":"J Branco","year":"2017","unstructured":"Branco, J. et al. Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance. Clin. Microbiol. Infect. 23, 575.e1\u2013575.e8 (2017).","journal-title":"Clin. Microbiol. Infect."},{"key":"173_CR86","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1128\/AAC.00842-15","volume":"59","author":"J Branco","year":"2015","unstructured":"Branco, J. et al. Fluconazole and voriconazole resistance in Candida parapsilosis is conferred by gain-of-function mutations in MRR1 transcription factor gene. Antimicrob. Agents Chemother. 59, 6629\u20136633 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR87","doi-asserted-by":"publisher","unstructured":"Doorley, L. A. et al. Candida parapsilosis Mdr1B and Cdr1B are drivers of Mrr1-mediated clinical fluconazole resistance. Antimicrob. Agents Chemotherapy e0028922, https:\/\/doi.org\/10.1128\/aac.00289-22 (2022).","DOI":"10.1128\/aac.00289-22"},{"key":"173_CR88","doi-asserted-by":"publisher","first-page":"e00402","DOI":"10.1128\/AAC.00402-20","volume":"64","author":"LR McTaggart","year":"2020","unstructured":"McTaggart, L. R., Cabrera, A., Cronin, K. & Kus, J. V. Antifungal susceptibility of clinical yeast isolates from a large canadian reference laboratory and application of whole-genome sequence analysis to elucidate mechanisms of acquired resistance. Antimicrob. Agents Chemother. 64, e00402\u2013e00420 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR89","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00889-22","volume":"66","author":"TY Kim","year":"2022","unstructured":"Kim, T. Y. et al. Evolution of fluconazole resistance mechanisms and clonal types of Candida parapsilosis isolates from a tertiary care hospital in South Korea. Antimicrob. Agents Chemother. 66, e0088922 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR90","doi-asserted-by":"publisher","first-page":"1655.e5","DOI":"10.1016\/j.cmi.2022.08.014","volume":"28","author":"J Branco","year":"2022","unstructured":"Branco, J. et al. Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation. Clin. Microbiol. Infect. 28, 1655.e5\u20131655.e8 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"173_CR91","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf051","volume":"7","author":"I Franconi","year":"2025","unstructured":"Franconi, I. et al. The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis. JAC Antimicrob. Resist 7, dlaf051 (2025).","journal-title":"JAC Antimicrob. Resist"},{"key":"173_CR92","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1128\/mBio.02512-19","volume":"10","author":"A Kannan","year":"2019","unstructured":"Kannan, A. et al. Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae. mBio 10, S1\u2013S159 (2019).","journal-title":"mBio"},{"key":"173_CR93","doi-asserted-by":"publisher","unstructured":"Rajesh-Khanna, D.-S. et al. Coordinated regulation of Mdr1- and Cdr1-mediated protection from antifungals by the Mrr1 transcription factor in emerging Candida spp. mBio. e0132325, https:\/\/doi.org\/10.1128\/mbio.01323-25 (2025).","DOI":"10.1128\/mbio.01323-25"},{"key":"173_CR94","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/jof6030138","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar, A. et al. The quiet and underappreciated rise of drug-resistant invasive fungal pathogens. J. Fungi 6, 138 (2020).","journal-title":"J. Fungi"},{"key":"173_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00651-17","volume":"61","author":"JM Rybak","year":"2017","unstructured":"Rybak, J. M. et al. Loss of C-5 sterol desaturase activity results in increased resistance to azole and echinocandin antifungals in a clinical isolate of Candida parapsilosis. Antimicrob. Agents Chemother. 61, 1\u201313 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mSphere.00821-20","volume":"5","author":"C Papp","year":"2020","unstructured":"Papp, C. et al. Triazole evolution of Candida parapsilosis results in cross-resistance to other antifungal drugs, influences stress responses, and alters virulence in an antifungal drug-dependent manner. mSphere 5, 1\u201315 (2020).","journal-title":"mSphere"},{"key":"173_CR97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11046-024-00847-0","volume":"189","author":"HO Khalifa","year":"2024","unstructured":"Khalifa, H. O., Watanabe, A. & Kamei, K. Genetic Mutations in FKS1 gene associated with acquired echinocandin resistance in Candida parapsilosis complex. Mycopathologia 189, 40 (2024).","journal-title":"Mycopathologia"},{"key":"173_CR98","doi-asserted-by":"publisher","first-page":"e00547","DOI":"10.1128\/mSphere.00547-18","volume":"3","author":"C Papp","year":"2018","unstructured":"Papp, C. et al. Echinocandin-induced microevolution of Candida parapsilosis influences virulence and abiotic stress tolerance. mSphere 3, e00547\u201318 (2018).","journal-title":"mSphere"},{"key":"173_CR99","doi-asserted-by":"publisher","unstructured":"Daneshnia, F. et al. Candida parapsilosis isolates carrying mutations outside of FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance. Int. J. Antimicrob. Agents 106831, https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106831 (2023).","DOI":"10.1016\/j.ijantimicag.2023.106831"},{"key":"173_CR100","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1128\/AAC.04922-14","volume":"59","author":"M Mart\u00ed-Carrizosa","year":"2015","unstructured":"Mart\u00ed-Carrizosa, M., S\u00e1nchez-Reus, F., March, F., Cant\u00f3n, E. & Coll, P. Implication of Candida parapsilosis FKS1 and FKS2 mutations in reduced echinocandin susceptibility. Antimicrob. Agents Chemother. 59, 3570\u20133573 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR101","doi-asserted-by":"publisher","first-page":"e00074","DOI":"10.1128\/cmr.00074-23","volume":"37","author":"M Hoenigl","year":"2024","unstructured":"Hoenigl, M. et al. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clin. Microbiol. Rev. 37, e00074\u201323 (2024).","journal-title":"Clin. Microbiol. Rev."},{"key":"173_CR102","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01028-22","volume":"66","author":"MA Pfaller","year":"2022","unstructured":"Pfaller, M. A., Huband, M. D., Rhomberg, P. R., Bien, P. A. & Castanheira, M. Activities of manogepix and comparators against 1435 recent fungal isolates collected during an International Surveillance Program (2020). Antimicrob. Agents Chemother. 66, e0102822 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01387-19","volume":"64","author":"M Kapoor","year":"2019","unstructured":"Kapoor, M., Moloney, M., Soltow, Q. A., Pillar, C. M. & Shaw, K. J. Evaluation of resistance development to the Gwt1 inhibitor manogepix (APX001A) in Candida species. Antimicrob. Agents Chemother. 64, 1\u201312 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR104","doi-asserted-by":"publisher","first-page":"e00429","DOI":"10.1128\/AAC.00429-20","volume":"64","author":"MC Arendrup","year":"2020","unstructured":"Arendrup, M. C. & J\u00f8rgensen, K. M. Manogepix (APX001A) displays potent in vitro activity against human pathogenic yeast, but with an unexpected correlation to fluconazole MICs. Antimicrob. Agents Chemother. 64, e00429\u201320 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR105","doi-asserted-by":"publisher","unstructured":"Barker, K. S. et al. Mutations in transcription factors that confer fluconazole resistance also confer reduced susceptibility to manogepix in Candida auris (Candidozyma auris), Candida albicans, Candida parapsilosis, and Candida glabrata (Nakaseomyces glabratus). Antimicrob. Agents Chemother. e00680-25, https:\/\/doi.org\/10.1128\/aac.00680-25 (2025).","DOI":"10.1128\/aac.00680-25"},{"key":"173_CR106","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00508-21","volume":"9","author":"F Yang","year":"2021","unstructured":"Yang, F. et al. Aneuploidy underlies tolerance and cross-tolerance to drugs in Candida parapsilosis. Microbiol. Spectr. 9, e0050821 (2021).","journal-title":"Microbiol. Spectr."},{"key":"173_CR107","doi-asserted-by":"publisher","first-page":"1137083","DOI":"10.3389\/fmicb.2023.1137083","volume":"14","author":"LL Sun","year":"2023","unstructured":"Sun, L. L. et al. Aneuploidy enables cross-tolerance to unrelated antifungal drugs in Candida parapsilosis. Front. Microbiol. 14, 1137083 (2023).","journal-title":"Front. Microbiol."},{"key":"173_CR108","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/S2666-5247(23)00294-X","volume":"5","author":"Y Ning","year":"2024","unstructured":"Ning, Y., Dai, R., Zhang, L., Xu, Y. & Xiao, M. Copy number variants of ERG11: mechanism of azole resistance in Candida parapsilosis. Lancet Microbe 5, e10 (2024).","journal-title":"Lancet Microbe"},{"key":"173_CR109","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1038\/s41591-024-03183-4","volume":"30","author":"B Zhai","year":"2024","unstructured":"Zhai, B. et al. Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections. Nat. Med. 30, 3163\u20133172 (2024).","journal-title":"Nat. Med."},{"key":"173_CR110","doi-asserted-by":"publisher","first-page":"e0404123","DOI":"10.1128\/spectrum.04041-23","volume":"12","author":"C Gautier","year":"2024","unstructured":"Gautier, C., Maciel, E. I. & Ene, I. V. Approaches for identifying and measuring heteroresistance in azole-susceptible Candida isolates. Microbiol. Spectr. 12, e0404123 (2024).","journal-title":"Microbiol. Spectr."},{"key":"173_CR111","doi-asserted-by":"publisher","unstructured":"Schutz, K. S. et al. Polygenetic determinants of azole resistance, tolerance, and heteroresistance in Candida albicans. bioRxiv, https:\/\/doi.org\/10.1101\/2025.06.29.662174 (2025).","DOI":"10.1101\/2025.06.29.662174"},{"key":"173_CR112","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.tim.2024.09.008","volume":"32","author":"A H\u00e9rivaux","year":"2024","unstructured":"H\u00e9rivaux, A., Papon, N. & Morio, F. Heteroresistance: a hidden cause behind antifungal prophylaxis failure. Trends Microbiol. 32, 1042\u20131044 (2024).","journal-title":"Trends Microbiol."},{"key":"173_CR113","doi-asserted-by":"publisher","unstructured":"Fekkar, A. et al. Hospital outbreak of fluconazole-resistant Candida parapsilosis: arguments for clonal transmission and long-term persistence. Antimicrob. Agents Chemotherapy https:\/\/doi.org\/10.1128\/AAC.02036-20 (2021).","DOI":"10.1128\/AAC.02036-20"},{"key":"173_CR114","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/jof8111228","volume":"8","author":"J D\u00edaz-Garc\u00eda","year":"2022","unstructured":"D\u00edaz-Garc\u00eda, J. et al. Candida genotyping of blood culture isolates from patients admitted to 16 hospitals in Madrid: genotype spreading during the COVID-19 pandemic driven by fluconazole-resistant C. parapsilosis. J. Fungi 8, 1228 (2022).","journal-title":"J. Fungi"},{"key":"173_CR115","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13706","volume":"67","author":"A Mesquida","year":"2024","unstructured":"Mesquida, A. et al. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: description of azole-resistance profiles associated with the Y132F ERG11p substitution. Mycoses 67, e13706 (2024).","journal-title":"Mycoses"},{"key":"173_CR116","doi-asserted-by":"publisher","unstructured":"Alcoceba, E. et al. Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2022.02.025 (2022).","DOI":"10.1016\/j.cmi.2022.02.025"},{"key":"173_CR117","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1128\/JCM.02321-09","volume":"48","author":"J Guinea","year":"2010","unstructured":"Guinea, J. et al. Rapid antifungal susceptibility determination for yeast isolates by use of Etest performed directly on blood samples from patients with fungemia. J. Clin. Microbiol. 48, 2205\u20132212 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"173_CR118","doi-asserted-by":"publisher","first-page":"e00162","DOI":"10.1128\/AAC.00162-18","volume":"62","author":"M\u00c1 Bordallo-Cardona","year":"2018","unstructured":"Bordallo-Cardona, M. \u00c1 et al. Resistance to echinocandins in Candida can be detected by performing the etest directly on blood culture samples. Antimicrob. Agents Chemother. 62, e00162\u201318 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR119","doi-asserted-by":"publisher","first-page":"e00400","DOI":"10.1128\/AAC.00400-17","volume":"61","author":"P Escribano","year":"2017","unstructured":"Escribano, P. et al. The Etest performed directly on blood culture bottles is a reliable tool for detection of fluconazole-resistant Candida albicans isolates. Antimicrob. Agents Chemother. 61, e00400\u2013e00417 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"173_CR120","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1157\/13052333","volume":"21","author":"MJ Linares","year":"2003","unstructured":"Linares, M. J., Charriel, G., Sol\u00eds, F. & Casal, M. CHROMAgar Candida with fluconazole: comparison with microdilution techniques]. Enferm. Infecc. Microbiol Clin. 21, 493\u2013497 (2003).","journal-title":"Enferm. Infecc. Microbiol Clin."},{"key":"173_CR121","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/diagnostics13020231","volume":"13","author":"A Ruiz-Gait\u00e1n","year":"2023","unstructured":"Ruiz-Gait\u00e1n, A. et al. Usefulness of chromogenic media with fluconazole supplementation for presumptive identification of Candida auris. Diagnostics 13, 231 (2023).","journal-title":"Diagnostics"},{"key":"173_CR122","unstructured":"Martin-Gomez, M. et al. Usefulness of Fluconazole-Supplemented Chromogenic Agar (FSCA) for the detection of fluconazole non-susceptible Candida parapsilosis (FNSCP) in clinical samples. In 32nd European Society of Clinical Microbiology and Infectious Diseases meeting. Lisbon (Portugal) from April 23 to 26 (2022)."},{"key":"173_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.645049","volume":"11","author":"E De Carolis","year":"2021","unstructured":"De Carolis, E. et al. Are we ready for nosocomial candida auris infections? Rapid identification and antifungal resistance detection using MALDI-TOF mass spectrometry may be the answer. Front. Cell Infect. Microbiol. 11, 645049 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"173_CR124","doi-asserted-by":"publisher","first-page":"e00420","DOI":"10.1128\/JCM.00420-18","volume":"56","author":"M Vatanshenassan","year":"2018","unstructured":"Vatanshenassan, M. et al. Proof of concept for MBT ASTRA, a rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based method to detect caspofungin resistance in Candida albicans and Candida glabrata. J. Clin. Microbiol. 56, e00420\u201318 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"173_CR125","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/jof7010063","volume":"7","author":"MA Knoll","year":"2021","unstructured":"Knoll, M. A., Ulmer, H. & Lass-Fl\u00f6rl, C. Rapid antifungal susceptibility testing of yeasts and molds by MALDI-TOF MS: a systematic review and meta-analysis. J. Fungi 7, 63 (2021).","journal-title":"J. Fungi"},{"key":"173_CR126","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/microorganisms8010109","volume":"8","author":"AEM Roberto","year":"2020","unstructured":"Roberto, A. E. M. et al. Rapid detection of echinocandins resistance by MALDI-TOF MS in Candida parapsilosis complex. Microorganisms 8, 109 (2020).","journal-title":"Microorganisms"},{"key":"173_CR127","doi-asserted-by":"publisher","first-page":"115957","DOI":"10.1016\/j.diagmicrobio.2023.115957","volume":"106","author":"CM Hubler","year":"2023","unstructured":"Hubler, C. M., Carvalhaes, C. G. & Castanheira, M. Recent increase in fluconazole-nonsusceptible Candida parapsilosis in a global surveillance with the expansion of the Erg11 Y132F genotype and a rapid detection method for this alteration. Diagn. Microbiol. Infect. Dis. 106, 115957 (2023).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"173_CR128","first-page":"e2024.345209.15","volume":"10","author":"K Karthika","year":"2024","unstructured":"Karthika, K., Premamalini, T., Vijayakishore, T. & Kindo, A. J. Standardization of polymerase chain reaction for detection of fluconazole resistance targeting Y132F mutation in ERG11 gene in Candida parapsilosis. Curr. Med. Mycol. 10, e2024.345209.1517 (2024).","journal-title":"Curr. Med. Mycol."},{"key":"173_CR129","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/mdr.2023.0198","volume":"30","author":"S \u00d6zt\u00fcrk","year":"2024","unstructured":"\u00d6zt\u00fcrk, S. et al. Rapid tetra-primer amplification refractory mutation system-polymerase chain reaction protocol for detection of Y132F mutation in fluconazole resistant Candida parapsilosis. Micro. Drug Resist. 30, 210\u2013213 (2024).","journal-title":"Micro. Drug Resist."},{"key":"173_CR130","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.cmi.2024.07.002","volume":"30","author":"J Guinea","year":"2024","unstructured":"Guinea, J. et al. Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme. Clin. Microbiol. Infect. 30, 1447\u20131452 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"173_CR131","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13811","volume":"67","author":"N Trevijano-Contador","year":"2024","unstructured":"Trevijano-Contador, N. et al. High-resolution melting assay to detect the mutations that cause the Y132F and G458S substitutions at the ERG11 gene involved in azole resistance in Candida parapsilosis. Mycoses 67, e13811 (2024).","journal-title":"Mycoses"},{"key":"173_CR132","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/microorganisms11041071","volume":"11","author":"N Mohammad","year":"2023","unstructured":"Mohammad, N. et al. Improving the detection of epidemic clones in Candida parapsilosis outbreaks by combining MALDI-TOF mass spectrometry and deep learning approaches. Microorganisms 11, 1071 (2023).","journal-title":"Microorganisms"},{"key":"173_CR133","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02388-23","volume":"11","author":"E De Carolis","year":"2023","unstructured":"De Carolis, E. et al. The Fourier-transform infrared spectroscopy-based method as a new typing tool for Candida parapsilosis clinical isolates. Microbiol. Spectr. 11, e0238823 (2023).","journal-title":"Microbiol. Spectr."},{"key":"173_CR134","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/jof10110753","volume":"10","author":"E De Carolis","year":"2024","unstructured":"De Carolis, E. et al. Follow the path: unveiling an azole resistant Candida parapsilosis outbreak by FTIR spectroscopy and STR analysis. J. Fungi 10, 753 (2024).","journal-title":"J. Fungi"},{"key":"173_CR135","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1038\/s41564-024-01819-2","volume":"9","author":"C B\u00e9dard","year":"2024","unstructured":"B\u00e9dard, C. et al. Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness cost. Nat. Microbiol. 9, 3025\u20133040 (2024).","journal-title":"Nat. Microbiol."},{"key":"173_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84535-5","volume":"15","author":"R El Hady","year":"2025","unstructured":"El Hady, R. et al. Phenotypic and genotypic characterization of Candida parapsilosis complex isolates from a Lebanese hospital. Sci. Rep. 15, 4853 (2025).","journal-title":"Sci. Rep."},{"key":"173_CR137","doi-asserted-by":"publisher","unstructured":"Steixner, S., Bauer, A., Grubwieser, P. & Lass-Fl\u00f6rl, C. Can we prevent azole-resistant Candida parapsilosis from becoming the next Candidozyma auris? Expert Rev. Anti Infect. Ther. 1\u20133, https:\/\/doi.org\/10.1080\/14787210.2025.2544694 (2025).","DOI":"10.1080\/14787210.2025.2544694"},{"key":"173_CR138","unstructured":"Infection Control Guidance: Candida auris. https:\/\/www.cdc.gov\/candida-auris\/hcp\/infection-control\/index.html (2024)."},{"key":"173_CR139","doi-asserted-by":"crossref","unstructured":"Jesudason, T. UKHSA publishes updated guidance for C auris. Lancet Microbe. 101151 (2025).","DOI":"10.1016\/j.lanmic.2025.101151"},{"key":"173_CR140","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/jac\/dkz204","volume":"74","author":"F Morio","year":"2019","unstructured":"Morio, F. et al. Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis. J. Antimicrob. Chemother. 74, 2230\u20132238 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"173_CR141","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","volume":"66","author":"F Morio","year":"2010","unstructured":"Morio, F., Loge, C., Besse, B., Hennequin, C. & Le Pape, P. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn. Microbiol. Infect. Dis. 66, 373\u2013384 (2010).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"173_CR142","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/jac\/dkad112","volume":"78","author":"F Daneshnia","year":"2023","unstructured":"Daneshnia, F. et al. Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis. J. Antimicrob. Chemother. 78, 1488\u20131494 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"173_CR143","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae264","volume":"11","author":"E Misas","year":"2024","unstructured":"Misas, E. et al. Molecular and Epidemiological Investigation of Fluconazole-resistant Candida parapsilosis-Georgia, United States, 2021. Open Forum Infect. Dis. 11, ofae264 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"173_CR144","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/jof8020100","volume":"8","author":"DY Thomaz","year":"2022","unstructured":"Thomaz, D. Y. et al. A Brazilian inter-hospital candidemia outbreak caused by fluconazole-resistant Candida parapsilosis in the COVID-19 Era. J. Fungi 8, 100 (2022).","journal-title":"J. Fungi"},{"key":"173_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1136217","volume":"13","author":"A Ceballos-Garzon","year":"2023","unstructured":"Ceballos-Garzon, A. et al. Emergence and circulation of azole-resistant C. albicans, C. auris and C. parapsilosis bloodstream isolates carrying Y132F, K143R or T220L Erg11p substitutions in Colombia. Front. Cell Infect. Microbiol. 13, 1136217 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"173_CR146","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13677","volume":"67","author":"M Zeeshan","year":"2024","unstructured":"Zeeshan, M. et al. Fluconazole-resistant Candida parapsilosis complex candidemia and analysis of mutations in the ERG11 gene from Pakistan. Mycoses 67, e13677 (2024).","journal-title":"Mycoses"},{"key":"173_CR147","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/jac\/dkaf015","volume":"80","author":"A Abdolrasouli","year":"2025","unstructured":"Abdolrasouli, A. et al. Cluster of clonal fluconazole-resistant Candida parapsilosis harbouring Y132F mutation in ERG11 gene in a neonatal ICU in the UK. J. Antimicrob. Chemother. 80, 887\u2013890 (2025).","journal-title":"J. Antimicrob. Chemother."}],"container-title":["npj Antimicrobials and Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00173-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00173-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00173-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:02:22Z","timestamp":1765911742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00173-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":147,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1038\/s44259-025-00173-5","relation":{},"ISSN":["2731-8745"],"issn-type":[{"value":"2731-8745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}